Leukemia Inhibitory Factor Recombinant Protein has been tested by biological activity and is suitable as a control for polyclonal or monoclonal anti-Leukemia Inhibitory Factor in immunological assays.
Bioactivity of Human Leukemia Inhibitory Factor Recombinant Protein. Serial dilutions of Human LIF (starting at 20 ng/mL) were added to TF1 cells. After 66 hours, cell proliferation was measured and the linear portion of the curve was us used to calculate the ED50. The ED50 of Human LIF is between 0.05-0.07 ng/mL.
* VAT and and shipping costs not included. Errors and price changes excepted